Harmony Net Profit Margin from 2010 to 2024

HRMY Stock  USD 34.67  1.08  3.02%   
Harmony Biosciences Net Profit Margin yearly trend continues to be fairly stable with very little volatility. Net Profit Margin is likely to outpace its year average in 2024. Net Profit Margin is the percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue. View All Fundamentals
 
Net Profit Margin  
First Reported
2010-12-31
Previous Quarter
0.22138854
Current Value
0.23
Quarterly Volatility
12.92885417
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Net Profit Margin Growth Pattern

Below is the plot of the Net Profit Margin of Harmony Biosciences Holdings over the last few years. It is the percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue. Harmony Biosciences' Net Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Net Profit Margin10 Years Trend
Slightly volatile
   Net Profit Margin   
       Timeline  

Harmony Net Profit Margin Regression Statistics

Arithmetic Mean(17.53)
Coefficient Of Variation(73.74)
Mean Deviation11.78
Median(26.36)
Standard Deviation12.93
Sample Variance167.16
Range26.7781
R-Value0.82
Mean Square Error59.04
R-Squared0.67
Significance0.0002
Slope2.37
Total Sum of Squares2,340

Harmony Net Profit Margin History

2024 0.23
2023 0.22
2022 0.41
2021 0.11
2020 -0.32

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Net Profit Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Profit Margin 0.22  0.23 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.